Epstein-Barr Virus (EBV) is among the world's most common and best-studied viruses. The
latent membrane protein 1 (LMP1) is an essential latent EBV gene variation. LMP1 is an …

EBV latent membrane protein 1 (LMP-1) is an important oncogene involved in the induction
and maintenance of EBV infection and the activation of several cell survival and proliferative …

Abstract Latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus (EBV) plays
an important role in EBV-induced cell transformation. Down-regulation of the LMP1 …

Epstein-Barr virus (EBV) was the first oncovirus found in humans. Almost all adults
worldwide are asymptomatic carriers of EBV. The latent EBV-infection malignifies in …

Abstract Latent membrane protein 1 (LMP1), a major oncoprotein of Epstein Barr Virus
(EBV) is responsible for transforming B lymphocytes in vitro. LMP1 is overexpressed in …

The Epstein–Barr virus (EBV) is a ubiquitous γ herpesvirus strongly associated with
nasopharyngeal carcinomas, and the viral oncogenicity in part relies on cellular effects of …

Abstract The Epstein–Barr virus (EBV) is a ubiquitous γ herpesvirus strongly associated with
nasopharyngeal carcinomas, and the viral oncogenicity in part relies on cellular effects of …

Epstein-Barr virus (EBV) is a ubiquitous virus with infections commonly resulting in a latency
carrier state. Although the exact role of EBV in cancer pathogenesis remains not entirely …

The oncogenic potential of Epstein–Barr virus (EBV) is mostly attributed to latent membrane
protein 1 (LMP1), which is essential and sufficient for transformation of fibroblast and primary …

Abstract Infection by the Epstein-Barr virus (EBV) is associated with a variety of human
cancers, notably Burkitt lymphoma and nasopharyngeal carcinoma (NPC). Most malignant …